Switch to:
More From Other Websites
Business Highlights Dec 19 2014
NovoEight®, phase 3 data show reduction in annualised bleeding rate over time in people with... Dec 10 2014
Share repurchase programme Dec 10 2014
How To Profit From The Obesity Epidemic Dec 08 2014
Paralegal: Sanofi fired her for whistleblowing Dec 05 2014
Paralegal: Sanofi fired her for whistleblowing Dec 05 2014
A Look At 4 ETFs From The 4 'Least Corrupt' Countries Dec 04 2014
Australian Diabetes Management Market and Diabetes Diagnostic Devices Market Spurted by $46 Million... Dec 01 2014
Share repurchase programme Dec 01 2014
[$$] Novo Could Put Money Where Its Mouth Is Nov 26 2014
Novo Nordisk's Victoza Recommended for Label Expansion Nov 24 2014
Changes in Novo Nordisk's Executive Management Nov 24 2014
Share repurchase programme Nov 24 2014
Sanofi Shakes Off Patent Losses Nov 24 2014
Victoza® receives positive CHMP opinion for use in adults with type 2 diabetes and moderate renal... Nov 21 2014
Sanofi's Bullish Pipeline Forecast Underwhelms Street Nov 20 2014
Share repurchase programme Nov 17 2014
Novo Nordisk second best in the world at providing access to medicine Nov 17 2014
Media Release - Top 100 Employer Nov 04 2014
New phase 3a data demonstrate that 9 out of 10 adults with obesity lost weight with liraglutide 3 mg... Nov 04 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

Gintaras58
ReplyGintaras58 - 9 months ago
few excellent prducts to come soon


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK